Syringes for Pfizer’s epoetin biosimilar have been outfitted with Needle-Trap needle protection labels from Schreiner MediPharm, a Germany-based provider of specialty pharmaceutical labeling solutions. The pairing marks the first time Needle-Trap will be used with medication for the treatment of anemia. The newly equipped needles will begin usage in Germany and Austria, followed by a rollout on the broader European market.   Pfizer sought a solution to protect healthcare personnel from needles...